Landec Corporation Sets Fourth Quarter 2022 Earnings Conference Call for August 10, 2022 at 2:00 p.m. PT
Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company, announced a conference call set for August 10, 2022, at 2:00 PM PT to discuss its fiscal 2022 fourth-quarter financial results. This call aims to provide insights into the performance of Lifecore Biomedical, a key division specializing in complex sterile injectable pharmaceutical products. Investors can access the live webcast on Landec's website, with a replay available until August 17, 2022. The company emphasizes its role as a leading contract development and manufacturing organization (CDMO) in the biopharmaceutical sector.
- Focus on Lifecore Biomedical, indicating growth in the CDMO sector.
- Hosting a conference call to engage investors and provide transparency.
- None.
SANTA MARIA, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced that it will host a conference call to discuss fiscal 2022 fourth quarter financial results. The live webcast can be accessed via Landec’s website on the Investor Events & Presentations page. The webcast will be available for 30 days.
Date: Wednesday, August 10, 2022
Time: 2:00 p.m. Pacific time (5:00 p.m. Eastern time)
Direct Webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1560352&tp_key=1933ba14f1
To participate in the conference call via telephone, dial toll-free: 1-877-407-3982 (U.S.) or 1-201-493-6780 (International). Please call the conference telephone number 5-10 minutes prior to the start time so the operator can register your name and organization.
A replay of the call will be available through August 17th, by calling toll-free: 1-844-512-2921 (U.S.) or 1-412-317-6671 (International), and entering code 13731657.
About Landec Corporation
Landec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Lifecore Biomedical, Inc. and Curation Foods, Inc. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. Curation Foods is focused on innovating and distributing plant-based foods with
Landec Corp. Contact Information:
Investor Relations
Jeff Sonnek
(646) 277-1263
jeff.sonnek@icrinc.com
FAQ
When will Landec Corporation discuss its fourth-quarter financial results?
How can I access Landec Corporation's conference call?
What is the focus of Lifecore Biomedical, a division of Landec Corporation?
Is there a replay available for Landec Corporation's conference call?
